With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Prospective Symptom Assessment in Children with Advanced Cancer||University of Wisconsin - Madison / Kathleen Montgomery, PhD & Jennifer Madden, RN/MSN||Nurse Researcher Grants||2015||Wisconsin|
|Targeting EZHIP as a therapeutic strategy for infantile ependymomas||University of Wisconsin - Madison / Peter Lewis, PhD||Innovation Grants||2021||Wisconsin|
|Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb||University of Wisconsin - Madison / Paul Sondel, MD, PhD||Innovation Grants||2015||Wisconsin|
|Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication||Marquette University / Amy Newman, RN, MSN||Nurse Researcher Grants||2014||Wisconsin|
|Molecular Signature of Inflammation||Medical College of Wisconsin / Subramaniam Malarkannan, PhD||Springboard Grants||2013||Wisconsin|
|Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy||University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD||Innovation Grants||2022||Wisconsin|
|Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure||Children's Hospital of Wisconsin - Milwaukee / Michael J. Burke, MD||Phase I/II Infrastructure Grants||2015||Wisconsin|
|Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing||Children's Hospital of Wisconsin - Milwaukee / Nathan Schloemer, MD||Young Investigator Grants||2016||Wisconsin|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|
|Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct||University of Wisconsin - Madison / Mario Otto||Young Investigator Grants||2012||Wisconsin|